OTIC Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa

News: OTIC Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa

Time: Friday, March 02, 2018 12:15

Intraday Maximum Change: $-0.475 - -8.52% Minutes After: 168

Latest Quote: 4.525 Change Since: $-1.525 - -33.7% Days Since: 81

Snapshot of company's key stats at the time of the event

Market Cap: 165,337,299 Shares Outstanding: 30,337,119 Float: 30,294,157

Day's Short Interest: 1,005,731 Short Ratio: 2.94%

Institutional Ownership: 32.9% Insider Ownership: 0%

OTIC - Otonomy Inc.

Sector: Healthcare - Industry: Biotechnology

Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear.

Subsidiary Scilex receives US FDA approval for non-opioid ZTlido (lidocaine topical system)

News: Subsidiary Scilex receives US FDA approval for non-opioid ZTlido (lidocaine topical system) 1.8% for PHN Pain; ZTlido uses novel technology demonstrating 12-Hour wear for efficient lidocaine delivery, even during exercise

Time: Wednesday, February 28, 2018 14:45

Link: http://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-therapeutics-subsidiary-scilex-receives-us-fda-approval

Intraday Maximum Change: $0.925 - 9.273% Minutes After: 61

Latest Quote: 7.2 Change Since: $-1.85 - -25.69% Days Since: 83

Snapshot of company's key stats at the time of the event

Market Cap: 698,755,673 Shares Outstanding: 82,692,979 Float: 0

Day's Short Interest: 3,111,259 Short Ratio: 1.01%

Institutional Ownership: 33.4% Insider Ownership: 0%

SRNE - Sorrento Therapeutics Inc.

Sector: Healthcare - Industry: Biotechnology

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.